Studies have shown that the number of NFTs in the brains of AD patients is positively correlated with the severity of the disease, suggesting that the abnormal phosphorylation and aggregation of tau are closely associated with the cognitive decline in AD [10,11]. The gene discussed is MAPT; the disease is Alzheimer disease.